PURPOSE: The aim of this study was to determine the changes in the health-related quality of life (HRQoL) and predictors of change among patients with multiple sclerosis (MS) at 3 and 6 years during the follow-up period. METHODS: A group of 109 consecutive MS patients (McDonald's criteria) referred to the Clinic of Neurology, Belgrade, were enrolled in the study. At three time points during the study (baseline, and at 3 and 6 years during the follow-up period), the HRQoL (measured by MSQoL-54), Expanded Disability Status Scale, and Hamilton Rating Scale for Depression and Fatigue Severity Scale were assessed. RESULTS: During the study period, 93 patients provided both follow-up assessments. Statistically significant deterioration in the HRQoL at each subsequent time point was detected for all scales of the MSQoL-54 except for the pain and change in health scales. A higher level of education was a significant prognostic factor for a better HRQoL on the cognitive function scale throughout the entire period of observation, while marital status (single, including divorced and widowed) and increased age at the onset of MS had significant predictive values of poorer quality-of-life scores on the overall quality-of-life scale at 6-year follow-up. Higher levels of physical disability and depression at baseline were statistically significant prognostic markers for deterioration in HRQoL for the majority of MSQoL-54 scales during the entire follow-up period. CONCLUSIONS: Our study suggests that baseline demographic and clinical characteristics could be applied as prognostic markers of the HRQOL for patients diagnosed with MS.
PURPOSE: The aim of this study was to determine the changes in the health-related quality of life (HRQoL) and predictors of change among patients with multiple sclerosis (MS) at 3 and 6 years during the follow-up period. METHODS: A group of 109 consecutive MS patients (McDonald's criteria) referred to the Clinic of Neurology, Belgrade, were enrolled in the study. At three time points during the study (baseline, and at 3 and 6 years during the follow-up period), the HRQoL (measured by MSQoL-54), Expanded Disability Status Scale, and Hamilton Rating Scale for Depression and Fatigue Severity Scale were assessed. RESULTS: During the study period, 93 patients provided both follow-up assessments. Statistically significant deterioration in the HRQoL at each subsequent time point was detected for all scales of the MSQoL-54 except for the pain and change in health scales. A higher level of education was a significant prognostic factor for a better HRQoL on the cognitive function scale throughout the entire period of observation, while marital status (single, including divorced and widowed) and increased age at the onset of MS had significant predictive values of poorer quality-of-life scores on the overall quality-of-life scale at 6-year follow-up. Higher levels of physical disability and depression at baseline were statistically significant prognostic markers for deterioration in HRQoL for the majority of MSQoL-54 scales during the entire follow-up period. CONCLUSIONS: Our study suggests that baseline demographic and clinical characteristics could be applied as prognostic markers of the HRQOL for patients diagnosed with MS.
Authors: Lydia Chwastiak; Dawn M Ehde; Laura E Gibbons; Mark Sullivan; James D Bowen; George H Kraft Journal: Am J Psychiatry Date: 2002-11 Impact factor: 18.112
Authors: Wilma M Hopman; Helen Coo; Andrey Pavlov; Andrew G Day; Catherine M Edgar; Evelyn V McBride; Donald G Brunet Journal: Can J Neurol Sci Date: 2009-09 Impact factor: 2.104
Authors: A Riazi; J C Hobart; D L Lamping; R Fitzpatrick; J A Freeman; C Jenkinson; V Peto; A J Thompson Journal: J Neurol Neurosurg Psychiatry Date: 2003-06 Impact factor: 10.154
Authors: Richard A Rudick; Deborah Miller; Steve Hass; Michael Hutchinson; Peter A Calabresi; Christian Confavreux; Steven L Galetta; Gavin Giovannoni; Eva Havrdova; Ludwig Kappos; Fred D Lublin; David H Miller; Paul W O'Connor; J Theodore Phillips; Chris H Polman; Ernst-Wilhelm Radue; William H Stuart; Andrzej Wajgt; Bianca Weinstock-Guttman; Daniel R Wynn; Frances Lynn; Michael A Panzara Journal: Ann Neurol Date: 2007-10 Impact factor: 10.422
Authors: W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky Journal: Ann Neurol Date: 2001-07 Impact factor: 10.422
Authors: Lindsay I Berrigan; John D Fisk; Scott B Patten; Helen Tremlett; Christina Wolfson; Sharon Warren; Kirsten M Fiest; Kyla A McKay; Ruth Ann Marrie Journal: Neurology Date: 2016-03-09 Impact factor: 9.910
Authors: Rosa M Martínez-Piédrola; Cristina García-Bravo; Elisabet Huertas-Hoyas; Patricia Sánchez-Herrera Baeza; Jorge Pérez-Corrales; Carlos Sánchez-Camarero; Marta Pérez-de-Heredia-Torres Journal: Occup Ther Int Date: 2021-08-16 Impact factor: 1.448
Authors: Una Nedeljkovic; Jelena Dackovic; Darija Kisic Tepavcevic; Irena Dujmovic Basuroski; Sarlota Mesaros; Tatjana Pekmezovic; Jelena Drulovic Journal: Arch Med Sci Date: 2015-03-18 Impact factor: 3.318